Celltrion Healthcare Rises 5.48% Amid K-New Deal Index (Bio) Theme Uptrend
On the 7th, the K-New Deal Index (Bio) theme showed a strong performance, rising 3.27% compared to the previous day, while Celltrion Healthcare, a related stock attracting attention, surged 5.48% from the previous day. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
[Graph] Major stock price changes in the K-New Deal Index (Bio) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Celltrion Healthcare's quant financial score is 42.54 points, showing higher stability and profitability scores than the average of other stocks related to the K-New Deal Index (Bio), but its quant financial ranking was only 6th out of 10 stocks. On the other hand, Seegene ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.
[Table] Top financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Reporters Who First Revealed Jo Jinwoong's Juvenile Offense History Cleared of Juvenile Act Violation"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.